Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza.
about
Isoflavones and PPAR Signaling: A Critical Target in Cardiovascular, Metastatic, and Metabolic DiseaseAnti-high mobility group box-1 monoclonal antibody treatment provides protection against influenza A virus (H1N1)-induced pneumonia in mice.Host response to influenza virus: protection versus immunopathology.Activity of Ingavirin (6-[2-(1H-Imidazol-4-yl)ethylamino]-5-oxo-hexanoic Acid) Against Human Respiratory Viruses in in Vivo ExperimentsPotential of Complementary and Alternative Medicine in Preventive Management of Novel H1N1 Flu (Swine Flu) Pandemic: Thwarting Potential Disasters in the Bud.Preventing and treating secondary bacterial infections with antiviral agentsSuppression of ongoing experimental arthritis by a chinese herbal formula (huo-luo-xiao-ling dan) involves changes in antigen-induced immunological and biochemical mediators of inflammation.Increased Survivorship and Altered Cytokine Profile from Treatment of Influenza A H1N1-Infected Mice with Ekybion: A Drug Complex of Natural Extracts and Inorganic CompoundsKolaviron Improves Morbidity and Suppresses Mortality by Mitigating Oxido-Inflammation in BALB/c Mice Infected with Influenza VirusThe cytokine storm of severe influenza and development of immunomodulatory therapyEffect of statin treatments on highly pathogenic avian influenza H5N1, seasonal and H1N1pdm09 virus infections in BALB/c miceImmunomodulatory therapy for severe influenza.Prevention and Treatment of Influenza, Influenza-Like Illness, and Common Cold by Herbal, Complementary, and Natural Therapies.
P2860
Q28387066-C0F750A7-48A5-4445-AD16-98F6A6246589Q30375577-EF1A99C4-8BA1-4A7A-9202-DEE6FC2A00C5Q30391010-6C1BA9D3-FA6A-4068-9709-654FE5A8BEBDQ30393969-D61AD152-7202-4B30-9E8C-D31CC2AE28E0Q30395281-3C2416A2-A560-44F6-B101-6BCD40CB66E6Q30401260-14FC149D-3577-4EF4-8C71-E27C4F9074B6Q34219054-5BE2B694-66FD-4CF2-8BA1-B62C12C63D8AQ34222409-C968F9AB-9670-4353-B073-28968F539A2BQ36030321-D1AD60EB-9A2B-431B-B591-A3ADFAAA6D5AQ36459143-40EAB5D1-0EC2-46DF-A9CC-C8B5F9098083Q36607954-07D12503-0E8B-43E6-ACEF-A03055EBF280Q37910249-45014F59-399D-4077-AA58-AEC8E1DF3CEFQ38801138-0EEB01E9-F230-4F8F-9917-EB9F3C56DE87
P2860
Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Using Complementary and Altern ...... ponse during Severe Influenza.
@ast
Using Complementary and Altern ...... ponse during Severe Influenza.
@en
type
label
Using Complementary and Altern ...... ponse during Severe Influenza.
@ast
Using Complementary and Altern ...... ponse during Severe Influenza.
@en
prefLabel
Using Complementary and Altern ...... ponse during Severe Influenza.
@ast
Using Complementary and Altern ...... ponse during Severe Influenza.
@en
P2093
P2860
P356
P1476
Using Complementary and Altern ...... ponse during Severe Influenza.
@en
P2093
Charles Cai
Ian A Clark
Lisa M Alleva
P2860
P304
P356
10.1093/ECAM/NEP152
P577
2009-09-24T00:00:00Z